Education only — not medical advice
How weight-loss medication works
When a licensed provider decides medication belongs in a weight plan, it’s worth understanding exactly what that medication is, how it’s made, and what the evidence does — and doesn’t — say. This page is that explanation, in plain language.
The medications, by name
Compounded semaglutide
FDA-Approved moleculeCompounded form not FDA-approvedSemaglutide is a GLP-1 receptor agonist — a synthetic version of a hormone your gut releases after eating. It acts on receptors that influence appetite and the feeling of fullness, and slows how quickly the stomach empties, which can reduce overall food intake.
Read the full semaglutide entry →Compounded tirzepatide
FDA-Approved moleculeCompounded form not FDA-approvedTirzepatide is a dual GIP/GLP-1 receptor agonist: it activates two gut-hormone receptors involved in appetite regulation and blood-sugar control, which together can reduce appetite and food intake.
Read the full tirzepatide entry →How compounding works
A compounding pharmacy is a licensed, state-inspected pharmacy that prepares a medication for an individual patient from a provider’s prescription. Diadara’s pharmacy partners compound these medications when a licensed provider determines it’s clinically appropriate for you — that decision is never automatic.
The distinction that matters: the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. The underlying molecules have been through that review in their brand-name forms; the compounded preparation you receive has not. Both halves of that sentence are true, and you should know both.
The evidence, honestly
Semaglutide and tirzepatide are FDA-approved molecules — evaluated in controlled clinical trials and reviewed by regulators for defined uses. That is the strongest evidence tier we label. It applies to the molecule, not to the compounded form a patient receives, which is why every mention here carries both the evidence label and the compounded disclosure — never a flat “FDA-approved” claim.
Safety notes
The most commonly reported side effects are gastrointestinal — nausea, vomiting, diarrhea, or constipation, especially early on. Both molecules carry a boxed warning for thyroid C-cell tumors based on rodent studies, and neither is appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. They can also interact with other medications — including insulin, sulfonylureas, and oral contraceptives — which is one reason a licensed provider reviews your full health history before any prescription is written, and stays with you through check-ins after it is.
If you experience severe or persistent symptoms while taking any weight-loss medication, contact your provider or seek medical care.